Skip to main content
SpringerLink
Log in

Etoposid, Adriamycin, Cisplatin beim fortgeschrittenen Magenkarzinom — Langzeitergebnisse bei 145 Patienten

  • Conference paper
Aktuelle Therapie gastrointestinaler Tumoren

  • 28 Accesses

Zusammenfassung

Durch die Entwicklung neuer Chemotherapieprogramme und multimodaler Behandlungskonzepte ist die Einstellung zur Systemtherapie des fortgeschrittenen Magenkarzinoms in den letzten Jahren wieder positiver geworden. Dies insbesondere, als auch mit sehr extensiven chirurgischen Eingriffen die Prognose dieses Tumors sich nicht entscheidend gebessert hat. Weiterhin versterben mehr als 80% aller Patienten mit einem neu diagnostizierten Magenkarzinom an ihrem Tumorleiden.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 64.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 84.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Flechtner H, Raeth U, Selbach J, Harjung H, Manegold C, Kabelitz K, Trux FA, Edler L, Queißer W (1988) Etoposide, adriamycin, cisplatinum (EAP) combination chemotherapy for advanced gastric cancer. Cancer Chemother Pharmacol 23 (Suppl):C 106 (abstr 422)

    Google Scholar 

  2. Katz A, Gansl R, Simon S, Gama-Rodrigues JJ, Waitzberg D, Bresciani C, Pinotti HV (1989) Phase II trial of VP-16 (V), adriamycin (A) and cisplatinum (C) in patients (pts) with advanced gastric cancer (AGC). Proc Amer Soc Clin Oncol 8: 98 (abstr 378)

    Google Scholar 

  3. Kim SY, Song MH, Park CS, Lee HY, Kim YK, Lee BH, An BJ (1989) Etoposide, adriamycin, and cisplatin (EAP) combination chemotherapy for advanced gastric cancer. Blut 59: 257 (abstr 15)

    Google Scholar 

  4. Klein HO, Wickramanayake PD, Farrkh GR (1986) 5-fluorouracil (5-FU), adriamycin (ADM), and methorexate (MTX) — a combination protocol (FAMTX) for treatment of metastasized stomach cancer. Proc Amer Soc Clin Oncol 5:86 (abstr)

    Google Scholar 

  5. Lerner A, Steele GD, Mayer RJ (1990) Etoposide, doxorubicin, cisplatin (EAP) chemotherapy for advanced gastric cancer: results of a phase II trial. Proc Amer Soc Clin Oncol 9: 103 (abstr 396)

    Google Scholar 

  6. Miller AB, Hoogstraten B, Staquet M (1981) Reporting results of cancer treatment. Cancer 47: 207–214

    Article  PubMed  CAS  Google Scholar 

  7. Preusser P, Achterrath W, Wilke H, Lenaz L, Fink U, Heinicke A, Meyer J, Bünte H (1988) Chemotherapy of gastric cancer. Cancer Treat Rev 15: 257–277

    Article  PubMed  CAS  Google Scholar 

  8. Preusser P, Wilke H, Achterrath W, Fink U, Heinicke A, Meyer J, Meyer H-J, Biinte H (1989) Phase II study with the combination etoposide, doxorubicin, and cisplatin in advanced measurable gastric cancer. J Clin Oncol 7: 1310–1317

    PubMed  CAS  Google Scholar 

  9. Taguchi T (1989) Combination chemotherapy with etoposide (E), adriamycin (A), and cisplatin (P) (EAP) for advanced gastric cancer. Proc Amer Soc Clin Oncol 8: 108 (abstr 420)

    Google Scholar 

  10. Wilke H, Preusser P, Fink U, Gunzer U, Meyer H-J, Meyer J, Siewert JR, Achterrath W, Lenaz L, Knipp H, Schmoll H-J (1989) Preoperative chemotherapy in locally advanced and nonresectable gastric cancer. A phase II study with etoposide, doxorubicin, and cisplatin. J Clin Oncol 7: 1318–1326

    PubMed  CAS  Google Scholar 

  11. Wilke H, Preusser P, Fink U, Achterrath W, Lenaz L, Stahl M, Schöber C, Link H, Meyer H-J, Schmoll H-J (1990) High dose folinic acid/etoposide/5-fluorouracil in advanced gastric cancer–a phase-II-study in elderly patients and patients with cardiac risk. Invest New Drugs 8: 65–70

    Article  PubMed  CAS  Google Scholar 

  12. Wilke H, Preusser P, Fink U, Achterrath W, Meyer H-J, Stahl M, Meyer J, Siewert JR, Geerlings H, Köhne-Wömpner CH, Harstrick H, Schmoll H-J (1990) New developments in gastric cancer. Sem Oncol 17 /1: 61–70

    CAS  Google Scholar 

  13. Wils J, Klein HO, Bleiberg H, Buyse M, Wagener DJTh, Conroy T, Diaz-Rubio E, Fickers M, Korsten F, Leyvraz S, Reis H, Duez N (1990) FAMTX (5-FU, adriamycin (A) and methotrexate (MTX): a step ahead in the treatment of advanced gastric cancer. Proc Amer Soc Clin Oncol 9: 102 (abstr 392)

    Google Scholar 

Download references

Authors
  1. H. Wilke
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Preusser
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. U. Fink
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H-J. Meyer
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. W. Achterrath
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M. Stahl
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. C.-H. Köhne-Wömpner
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. A. Harstrick
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. J. Meyer
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. G. Wegener
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. J. R. Siewert
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. H-J. Schmoll
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Abteilung Hämatologie und Onkologie, Medizinische Hochschule Hannover, Konstanty-Gutschow-Str. 8, 3000, Hannover 61, Deutschland

    Hans-Joachim Schmoll

  2. Klinik für Abdominal- und Transplantationschirurgie, Zentrum Chirurgie der Medizinischen Hochschule Hannover, Konstanty-Gutschow-Str. 8, 3000, Hannover 61, Deutschland

    Hans-Joachim Meyer  & Rudolf Pichlmayr  & 

  3. Westdeutsches Tumorzentrum Essen, Innere Klinik und Poliklinik, Hufelandstr. 55, 4300, Essen 1, Deutschland

    Hansjochen Wilke

Rights and permissions

Reprints and permissions

Copyright information

© 1992 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Wilke, H. et al. (1992). Etoposid, Adriamycin, Cisplatin beim fortgeschrittenen Magenkarzinom — Langzeitergebnisse bei 145 Patienten. In: Schmoll, HJ., Meyer, HJ., Wilke, H., Pichlmayr, R. (eds) Aktuelle Therapie gastrointestinaler Tumoren. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-76187-4_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-76187-4_17

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-76188-1

  • Online ISBN: 978-3-642-76187-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation